The Role of Exosomes in Dry AMD

Project Summary

Our research seeks to understand what causes the earliest stages of the dry form of age-related macular degeneration (AMD), a common disease that damages the back of the eye (retina). AMD is one of the leading causes of blindness in the United States. Our research is specifically designed to elucidate whether lipid vesicles released from the RPE, known as exosomes and microvesicles, play a role in the development of AMD.

The first aim is to determine the protein composition and physical characteristics of lipid vesicles (e.g., exosomes and microvesicles) released apically and basolaterally from highly polarized primary RPE cell cultures under physiologically relevant conditions. These determinations will be done for pig RPE cell cultures and both young and old human RPE cell cultures. By comparing the cultures, we will know whether pig RPE cell cultures are an accurate model of human RPE cells. 

The second aim is to determine whether exposure of RPE cell cultures to oxidative stress, something thought to occur in the AMD disease process, will affect the release and composition of these lipid vesicles (e.g., exosomes and microvesicles). Comparisons to findings in normal pig and human RPE cell cultures will help identify new targets for treatment of AMD.

The studies to be carried out by Dr Klingeborn are unique in that exosomes and microvesicles have not been investigated in relation to AMD. The role of these lipid vesicles in other diseases, such as cancer, has proven to be considerable. Thus, the result from these experiments may help us find new drugs to treat sick RPE cells and preserve the eyesight of people with dry AMD.